ARCHIVES

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

This article is from The Cancer Letter archive.

Vol. 36 No. 36 | October 8, 2010

Download PDF Visit The Full Archive

Related Articles

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

ONS Adopts Position Statement On Rehabilitation

May 5, 1989

Without Advance Directives, Families Prolong Treatment

April 27, 2001

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

January 22, 1982